Status:
UNKNOWN
Korean Registry of Target Organ Damages in Hypertension
Lead Sponsor:
Dongtan Sacred Heart Hospital
Conditions:
Hypertension
Eligibility:
All Genders
30+ years
Brief Summary
The objective of this study is to know prevalence of clinical or subclinical target organ damages in Korea hypertensives by constructing nationwide hypertension registry. We will register 5000 consecu...
Detailed Description
Background: the exact prevalence of target organ damages in Korean hypertensives are unknown. Study Objective: to investigate the prevalence of target organ damages in Korean patients with incident h...
Eligibility Criteria
Inclusion
- age≧30years
- primary incident hypertension
- singed informed consent
Exclusion
- participated in other clinical trials
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT01861080
Start Date
May 1 2013
End Date
December 31 2021
Last Update
February 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hallym University Dongtan Sacred Heart Hospital,
Hwaseong, Gyeonggido, South Korea, 445-170